Publications by authors named "V P Llorens"
Article Synopsis
- The text refers to a correction made to a previously published article, identified by its DOI number (10.3389/fimmu.2022.1105343).
- Corrections in scientific articles are important to ensure the accuracy and reliability of the research findings.
- The specifics of what was corrected are not mentioned in the text provided.
Article Synopsis
- - The study evaluates the effectiveness and safety of adalimumab in treating non-infectious uveitis across four Spanish hospitals from 2012 to 2022, analyzing patient data on relapses, inflammation, and medication dosage changes.
- - Out of 122 patients, most were middle-aged Caucasian women with refractory uveitis; results showed significant reductions in both relapses and corticosteroid use, along with improved visual acuity.
- - Overall, adalimumab demonstrated high efficacy and safety in managing non-infectious uveitis, with minimal serious side effects and a low incidence of anti-drug antibody development.
Population isolates such as those in Finland benefit genetic research because deleterious alleles are often concentrated on a small number of low-frequency variants (0.1% ≤ minor allele frequency < 5%). These variants survived the founding bottleneck rather than being distributed over a large number of ultrarare variants.
View Article and Find Full Text PDF